Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Defibrotide in High Risk Kawasaki Disease
NCT04777422Phase 2Unknown
- Sponsor
- New York Medical College
- Start
- Feb 2021
- Primary completion
- Oct 2023
- Modality
- Antisense DNA, Small Interfering RNA (siRNA), Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of defibrotide in Kawasaki disease (KD), sponsored by New York Medical College. Status: unknown.
02
Drugs
defibrotide
03
Conditions
Kawasaki disease (KD)
Beyond the preview
Go deeper on NCT04777422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04777422.